<DOC>
	<DOCNO>NCT01029470</DOCNO>
	<brief_summary>Primary objective : To evaluate efficacy term oocyte retrieval number rLH supplement woman hyporesponse rFSH pituitary downregulation . Secondary objective : To explore efficacy rLH supplement woman hyporesponse rFSH pituitary downregulation To evaluate safety rLH supplementation hyporesponse woman</brief_summary>
	<brief_title>To Describe Effect rhLH Supplementation Women With Hyporesponse rhFSH After Pituitary Downregulation</brief_title>
	<detailed_description>Primary endpoint : Number oocyte retrieve Secondary endpoint : 1 . Oestrodial hCG day ( pg/ml ) 2 . Number embryos 3 . Implantation rate ( % ) 4 . Clinical pregnancy rate ( % ) 5 . Ongoing PR per IVF cycle ( % ) 6 . Abortion rate ( % ) 7 . Ampoules rFSH 8 . FertiQoL score Safety endpoint : adverse event</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Pituitary Diseases</mesh_term>
	<criteria>1 . 2040 year old woman 2 . With menstrual cycle range 2435 day , intraindividual variability±3 day 3 . Basal FSH &lt; 10 IU/L cycle D2D5 4 . 18 &lt; BMI &lt; 30 5 . Presence two ovary 6 . No ovarian stimulation past 3 month 7 . Signed inform consent form . 1 . Polycystic ovarian syndrome 2. rAFS stage ⅢⅣ endometriosis 3 . Chromosomal abnormality , endocrinological and/or autoimmune disorder . 4 . More two previously unsuccessful IVF .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Luveris</keyword>
	<keyword>hyporesponse</keyword>
	<keyword>pituitary downregulation</keyword>
	<keyword>IVF</keyword>
	<keyword>Infertility woman</keyword>
</DOC>